Richard Close
Stock Analyst at Canaccord Genuity
(2.13)
# 2,770
Out of 4,736 analysts
129
Total ratings
41.18%
Success rate
-6.66%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Buy | $11 → $10 | $5.65 | +77.15% | 7 | Jan 21, 2025 | |
| ACCD Accolade | Downgrades: Hold | n/a | $6.91 | - | 9 | Jan 8, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $36 → $42 | $38.09 | +10.27% | 3 | Jan 3, 2025 | |
| PGNY Progyny | Maintains: Hold | $18 → $17 | $21.16 | -19.66% | 5 | Nov 13, 2024 | |
| DOCS Doximity | Downgrades: Hold | $40 → $60 | $56.01 | +7.12% | 8 | Nov 13, 2024 | |
| PINC Premier | Maintains: Hold | $19 → $21 | $21.90 | -4.09% | 11 | Nov 6, 2024 | |
| AHCO AdaptHealth | Maintains: Buy | $14 → $13 | $10.13 | +28.33% | 6 | Nov 6, 2024 | |
| HSTM HealthStream | Maintains: Hold | $28 → $29 | $31.60 | -8.23% | 5 | Oct 23, 2024 | |
| PHR Phreesia | Maintains: Buy | $34 | $27.36 | +24.27% | 8 | Sep 5, 2024 | |
| QIPT Quipt Home Medical | Maintains: Buy | $8 → $6 | $2.95 | +103.39% | 3 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $17 | $9.99 | +70.26% | 15 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $117 → $121 | $125.94 | -3.92% | 3 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $26 | $22.74 | +14.34% | 7 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $41 | $9.95 | +312.06% | 10 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $4.36 | +14.68% | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $4.27 | -29.66% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1,170 → $225 | $1.82 | +12,290.55% | 6 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $29.47 | -18.55% | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $79 → $95 | $78.21 | +21.47% | 9 | Apr 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $19 → $18 | $52.80 | -66.38% | 4 | Dec 20, 2018 |
Health Catalyst
Jan 21, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $5.65
Upside: +77.15%
Accolade
Jan 8, 2025
Downgrades: Hold
Price Target: n/a
Current: $6.91
Upside: -
Waystar Holding
Jan 3, 2025
Maintains: Buy
Price Target: $36 → $42
Current: $38.09
Upside: +10.27%
Progyny
Nov 13, 2024
Maintains: Hold
Price Target: $18 → $17
Current: $21.16
Upside: -19.66%
Doximity
Nov 13, 2024
Downgrades: Hold
Price Target: $40 → $60
Current: $56.01
Upside: +7.12%
Premier
Nov 6, 2024
Maintains: Hold
Price Target: $19 → $21
Current: $21.90
Upside: -4.09%
AdaptHealth
Nov 6, 2024
Maintains: Buy
Price Target: $14 → $13
Current: $10.13
Upside: +28.33%
HealthStream
Oct 23, 2024
Maintains: Hold
Price Target: $28 → $29
Current: $31.60
Upside: -8.23%
Phreesia
Sep 5, 2024
Maintains: Buy
Price Target: $34
Current: $27.36
Upside: +24.27%
Quipt Home Medical
Aug 16, 2024
Maintains: Buy
Price Target: $8 → $6
Current: $2.95
Upside: +103.39%
Aug 1, 2024
Maintains: Buy
Price Target: $25 → $17
Current: $9.99
Upside: +70.26%
Jul 31, 2024
Maintains: Neutral
Price Target: $117 → $121
Current: $125.94
Upside: -3.92%
May 10, 2024
Maintains: Buy
Price Target: $37 → $26
Current: $22.74
Upside: +14.34%
May 10, 2024
Maintains: Buy
Price Target: $44 → $41
Current: $9.95
Upside: +312.06%
May 9, 2024
Maintains: Buy
Price Target: $9 → $5
Current: $4.36
Upside: +14.68%
Mar 6, 2023
Maintains: Buy
Price Target: $4 → $3
Current: $4.27
Upside: -29.66%
Mar 9, 2022
Maintains: Hold
Price Target: $1,170 → $225
Current: $1.82
Upside: +12,290.55%
Aug 4, 2021
Maintains: Buy
Price Target: $22 → $24
Current: $29.47
Upside: -18.55%
Apr 22, 2021
Maintains: Hold
Price Target: $79 → $95
Current: $78.21
Upside: +21.47%
Dec 20, 2018
Downgrades: Hold
Price Target: $19 → $18
Current: $52.80
Upside: -66.38%